@article{9e97b8a17fad40bd952aa0207fb25f36,
title = "Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review",
keywords = "STEM-CELL TRANSPLANTATION, TUMOR LYSIS SYNDROME, OPEN-LABEL, PERIPHERAL NEUROPATHY, WORKING GROUP, PHASE-II, SUBCUTANEOUS BORTEZOMIB, MELPHALAN-PREDNISONE, MULTICENTER, COMBINATION, 3122 Cancers",
author = "McCaughan, \{Georgia J.\} and Sara Gandolfi and Moore, \{John J.\} and Richardson, \{Paul G.\}",
year = "2022",
month = oct,
doi = "10.1111/bjh.18295",
language = "English",
volume = "199",
pages = "190--204",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley and Sons Inc",
number = "2",
}